Effects of 2-Chloro-9-(2-deoxy-2-fluoro-/3-D-arabinofuranosyl)adenine on K562 Cellular Metabolism and the Inhibition of Human Ribonucleotide Reductase and DNA Polymerases by Its 5'-Triphosphate

Cancer Research

Volumn 51, Issue 9, 1991, Pages 2386-2394

  Parker, William B ^a   Shaddix, Sue C ^a   Chang, Chi Hsiung ^a   Lucile White, E ^a   Rose, Lucy M ^a   Wallace Brockman, R ^a   Shortnacy, Anita T ^a   Montgomery, John A ^a   Secrist HI, John A ^a   Lee Bennett, L ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 2' DEOXY 2' FLUOROVIDARABINE; ANTIMETABOLITE; DNA POLYMERASE; RIBONUCLEOTIDE REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL METABOLISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ARABINONUCLEOSIDES; CELL DIVISION; COMPARATIVE STUDY; CYTIDINE TRIPHOSPHATE; DEOXYCYTIDINE; DNA; DNA-DIRECTED DNA POLYMERASE; GUANIDINE; GUANIDINES; HUMAN; RIBONUCLEOTIDE REDUCTASES; RNA; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0025811415     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Keating, M. J., Kantarjian, H., Talpaz, M., Redman, J., Roller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E. J., and McCredie, K. B. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood, 74:19-25,1989.
2. Carson, D. A., Wasson, W. B., and Beutler, E. Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine. Proc. Natl. Acad. Sci. USA, 81:2232-2236,1984.
3. Piro, L. D., Carrera, C. J., Beutler, E., and Carson, D. A. 2-Chlorodeoxy-adenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood, 72:1069-1073, 1988.
4. Piro, L. D., Carrera, C. J., Carson, D. A., and Beutler, E. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadeno-sine. N. Engl. J. Med., 322: 1117-1121, 1990.
5. White, E. L., Shaddix, S. C., Brockman, R. W., and Bennett, L. L., Jr. Comparison of the actions of 9-/3-D-arabinofuranosyl-2-fluoroadenine and 9-0-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. Cancer Res., 42:2260-2264, 1982.
6. Tseng, W-C., Derse, D., Cheng, Y-C., Brockman, R. W., and Bennett, L. L., Jr. In vitro biological activity of 9-0-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol. Pharmacol., 21:474-477,1982.
7. Parker, W. B., Bapat, A. R., Shen, J-X., Townsend, A. J., and Cheng, Y-C. Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase. Mol. Pharmacol., 34:485-491, 1988.
8. Huang, P., Chubb, S., and Plunkett, W. Termination of DNA synthesis by 9-0-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. J. Biol. Chem., 265:16617-16625,1990.
9. Parker, W. B., and Cheng, Y-C. Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs. Mol. Pharmacol., 31:146151, 1987.
10. Catapano, C. V., Chandler, K. B., and Fernandes, D. J. Effects of anticancer agents on primer RNA formation in human leukemia cells. Proc. Am. Assoc. Cancer Res., 31:2496, 1990.
11. GrifTig, J., Koob, R., and Blakley, R. L. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res., 49:6923-6928, 1989.
12. Hentosh, P., Koob, R., and Blakley, R. L. Incorporation of 2-halogeno-2'-deoxyadenosine 5'-triphosphates into DNA during replication by human polymerases a and 0. J. Biol. Chem., 265:4033-4040,1990.
13. Hirota, Y., Yoshioka, A., Tanaka, S., Watanabe, K., Otani, T., Minowada, J., Matsuda, A., Ueda, T., and Wataya, Y. Imbalance of deoxynucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res., 49:915-919, 1989.
14. Avramis, V. I., and Plunkett, W. Metabolism of 9-0-D-arabinosyl-2-fluoroad-enine-4'-phosphate by mice bearing P388 leukemia. Cancer Drug Delivery, /: 1-10, 1983.
15. Noker, P. E., Duncan, G. F., El Dareer, S. M., and Hill, D. L. Disposition of 9-0-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs. Cancer Treat. Rep., 67:445-456,1983.
16. Huang, P., and Plunkett, W. Phosphorolytic cleavage of 2-fluoroadenine from 9-/?-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. Biochem. Pharmacol., 36:2945-2950,1987.
17. Bennett, L. L., Jr., Vail, M. H., Chumley, S., and Montgomery, J. A. Activity of adenosine analogs against a cell culture line resistant to 2-fluoroadenine. Biochem. Pharmacol., 15: 1719-1728,1966.
18. Montgomery, J. A. Studies on the biologic activity of purine and pyrimidine analogs. Med. Res. Rev., 2:271-308, 1982.
19. Stoeckler, J. D., Bell, C. A., Parks, R. E., Jr., Chu, C. K., Fox, J. J., and Ikehara, M. C(2'substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotides. Biochem. Pharmacol., 31:1723-1728, 1982.
20. Secrist, J. A., Ill, and Montgomery, J. A. Analogs of fludarabine resistant to metabolic cleavage. Proc. Am. Assoc. Cancer Res., 30:2362,1989.
21. Parker, W. B., and Shaddix, S. C. Effect of 2-Cl-2'-F-2'-deoxyarabinofura-nosyladenine on nucleotide pools and its triphosphate on human DNA polymerases. Proc. Am. Assoc. Cancer Res., 31:2504, 1990.
22. Montgomery, J. A., Clayton, S. D., and Shortnacy, A. T. An improved procedure for the preparation of 9-0-D-arabinofuranosyl-2-fluoroadenine. J. Heterocycl. Chem., 16:157-160,1979.
23. Huang, M. C., Hatfield, K., Roetker, A. W., Montgomery, J. A., and Blakely, R. L. Analogs of 2'-deoxyadenosine: facile enzymatic preparation and growth inhibitory effects on human cell lines. Biochem. Pharmacol., 19:2663-2671, 1981.
24. Bennett, L. L., Jr., Smithers, D., Hill, D. L., Rose, L. M., and Alexander, J. A. Biochemical properties of the nucleoside of 3-amino-1,5-dihydro-5-methyl-l,4,5,6,8-pentaazaacenaphthylene (NSC-154020). Biochem. Pharmacol., 27: 233-241, 1978.
25. Cory, J. G., Russell, F. A., and Mansell, M. M. A convenient assay for ADP reductase activity using Dowex-1-borate columns. Anal. Biochem., 55:449456, 1973.
26. Solter, A. W., and Handschumacher, R. E. A rapid quantitative determination of deoxynucleoside triphosphates based on the enzymatic synthesis of DNA. Biochim. Biophys. Acta, 174:585-590, 1969.
27. Parker, W. B., White, E. L., Shaddix, S. C., Ross, L. J., Buckheit, R. W., Germany, J. M., Vince, R., Secrist, J. A., Ill, and Shannon, W. M. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases a, 0, y by the 5'-triphosphates of carbovir, 3' -azido-3' -deoxythymidine, 2', 3 '-dideoxyguanosine, and 3'-deoxythymi-dine. A novel RNA template for the evaluation of antiretroviral drugs. J. Biol. Chem., 266: 1754-1762, 1991.
28. Baril, E., Mitchener, J., Lee, L., and Baril, B. Action of pancreatic DNase: requirements for activation of DNA as a template-primer for DNA polymerase a. Nucleic Acids Res., 4:2641-2653,1977.
29. Boosalis, M. S., Petruska, J., and Goodman, M. F. DNA polymerase insertion fidelity. Gel assay for site-specific kinetics. J. Biol. Chem., 262:1468914696, 1987.
30. Townsend, A. J., and Cheng, Y-C. Sequence-specific effects of ara-5-aza-CTP and araCTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template. Mol. Pharmacol., 32:330-339,1987.
31. St. Clair, M. H., Richards, C. A., Spector, T., Weinhold, K. J., Miller, W. H., Langlois, A. J., and Furman, P. A. 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob. Agents Chemother., 31:1972-1977, 1987.
32. Reid, R., Mar, E-C., Huang, E-S., and Topal, M. D. Insertion and extension of acyclic, dideoxy, and ara nucleotides by Herpesviridae, human a, and human 0 polymerases. A unique inhibition mechanism for 9-(l,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J. Biol. Chem., 263: 3898-3904, 1988.
33. Ohno, Y., Spriggs, D., Matsukage, A., Ohno, T., and Kufe, D. Effects of 1-0-D-arabinofuranoxylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase 0. Cancer Res., 48: 1494-1498,1988.
34. Ohno, Y., Spriggs, D., Matsukage, A., Ohno, T., and Kufe, D. Sequence-specific inhibition of DNA strand elongation by incorporation of 9-0-d-arabinofuranoxyladenine. Cancer Res., 49:2077-2081, 1989.
35. Huang, P., Farquhar, D., and Plunkett, W. Selective action of 3'-azido-3 deoxythymidine 5'-triphosphate on viral reverse transcriptases and human DNA polymerases. J. Biol. Chem., 265: 11914-11918,1990.
36. Hao, Z., Cooney, D. A., Farquhar, D., Perno, C. F., Zhang, K., Masood, R., Wilson, Y., Hartman, N. R., Balzarini, J., and Johns, D. G. Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2', 3' -dideoxyuridine-5'-triphosphate. Mol. Pharmacol., 37: 157-163,1990.
37. Kedar, P. S., Abbotts, J., Kovacs, T., Lesiak, K., Torrence, P., and Wilson, S. H. Mechanism of HIV reverse transcriptase: enzyme-primer interaction as revealed through studies of a dNTP analogue, 3'-azido-dTTP. Biochemistry, 29:3603-3611,1990.
38. Weiner, P. K., and Kollman, P. A. AMBER: Assisted Model Building with Energy Refinement. A general program for modeling molecules and their interactions. J. Comput. Chem., 2:287-303,1981.
39. Heinemann, V., Hertel, L. W., Grindey, G. B., and Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-0-D-arabinofurosylcytosine. Cancer Res., 48:4024-4031,1988.
40. Huang, P., Chubb, S., Hertel, L. W., and Plunkett, W. Mechanism of action of 2', 2 '-difluorodeoxycytidine on DNA synthesis. Proc. Am. Assoc. Cancer Res., 31: 2530, 1990.
41. De Clercq, E. Commentary. Biochemical aspects of the selective antiherpes activity of nucleoside analogs. Biochem. Pharmacol., 33:2159-2169,1984.
42. Chou, T-C., Burchenal, J. H., Schmid, F. A., Braun, T. J., Su, T-L., Watanabe, K. A., Fox, J. J., and Philips, F. S. Biochemical effects of 2'-fluoro-5-methyl-1-0-D-arabinofuranoxyluracil and 2' -fluoro-5-iodo-1-0-D-ar-abinofuranosyluracil in mouse leukemia cells sensitive and resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res., 42:3957-3963, 1982.
43. Chu, C. K., Matulic-Adamic, J., Huang, J-T., Chou, T-C., Burchenal, J. H., Fox, J. J., and Watanabe, K. A. Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-0-D-arabinofuranosyl)-9H-purines and their biological activities. Chem. Pharm. Bull. (Jpn), 37:336-339, 1989.
44. Ruth, J. L., and Cheng, Y-C. Nucleoside analogs with clinical potential in antivirus chemotherapy. The effect of several thymidine and 2'-deoxycytidine analogue 5'-triphosphates on purified human (a,0) and herpes simplex virus (types 1,2) DNA polymerases. Mol. Pharmacol., 20:415-422, 1981.
45. Mikita, T., and Beardsley, G. P. Functional consequences of the arabinosyl-cytosine structural lesion in DNA. Biochemistry, 27:4698-4705,1988.